Commitments and Contingencies (Details) - Drug Supplier Project Plan $ in Millions |
Mar. 31, 2024
USD ($)
|
---|---|
Other Commitments [Line Items] | |
Total commitments | $ 1.0 |
Commitments for drug manufacturing | 0.8 |
Commitments for drug testing | 0.2 |
Commitments expected to incur over the next twelve months | $ 0.1 |
X | ||||||||||
- Definition Commitments under the Company's drug supplier project plan pertaining to the manufacturing of the Company's Grb2 drug substance. No definition available.
|
X | ||||||||||
- Definition Commitments under the Company's drug supplier project plan pertaining to the testing of the Company's Grb2 drug substance. No definition available.
|
X | ||||||||||
- Definition Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions. No definition available.
|
X | ||||||||||
- Definition Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|